COVID-19孕妇的妊娠与新生儿结局:PAN-COVID与AAP-SONPM登记研究的核心结局报告
该研究分析英国PAN-COVID登记(2020年1月1日至7月25日)和美国AAP-SONPM登记(2020年4月4日至8月8日)中4005例疑似或确诊SARS-CoV-2感染的孕妇,报告母婴结局。结果显示早产率高于历史数据,而死产、小于胎龄儿和早期新生儿死亡与历史数据相当;产妇死亡虽不常见但高于预期,可能因PAN-COVID中轻症或无症状感染漏检所致。
要点
- 确诊感染孕妇早产率分别为16.1%(PAN-COVID)和15.7%(AAP-SONPM)。
- 新生儿SARS-CoV-2感染率在确诊感染中为2.0%(PAN-COVID)和1.8%(AAP-SONPM)。
- 产妇死亡率在确诊感染中分别为0.5%(PAN-COVID)和0.2%(AAP-SONPM)。
核心结论
- 早产比例高于基于历史和同期全国数据的预期。
- 死产、小于胎龄儿和早期新生儿死亡比例与历史及同期英美数据相当。
- 产妇死亡虽不常见但高于英美人口数据预期,可能因PAN-COVID中轻症或无症状感染漏检所致。
- 数据支持加强预防妊娠期SARS-CoV-2感染的指导,并优先为孕妇和计划妊娠女性接种疫苗。
研究设计与样本
- 分析PAN-COVID登记(2020年1月1日至7月25日)中疑似或确诊SARS-CoV-2感染的孕妇。
- 分析AAP-SONPM国家围产期COVID-19登记(2020年4月4日至8月8日)中产前14天至产后3天SARS-CoV-2检测阳性的孕妇。
- 共报告4005例孕妇,其中PAN-COVID 1606例,AAP-SONPM 2399例。
主要发现
- 产妇死亡在PAN-COVID总体、PAN-COVID确诊感染和AAP-SONPM中分别为0.5%、0.5%和0.2%。
- 早期新生儿死亡在以上三组中分别为0.2%、0.3%和0.3%。
- 死产在以上三组中分别为0.5%、0.6%和0.4%。
- 早产(<37周)在PAN-COVID总体、PAN-COVID确诊感染和AAP-SONPM中分别为12.0%、16.1%和15.7%。
- 极早早产(<27周)在PAN-COVID中为0.5%,在AAP-SONPM中为0.3%。
临床怎么用
- 应加强预防妊娠期SARS-CoV-2感染的措施,尤其考虑到早产和产妇死亡风险增加。
- 优先为孕妇和计划妊娠女性接种疫苗。
局限性
- PAN-COVID研究可能存在轻症或无症状感染孕妇的漏检,影响产妇死亡率等估计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Few large cohort studies have reported data on maternal, fetal, perinatal and neonatal outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy. We report the outcome of infected pregnancies from a collaboration formed early during the pandemic between the investigators of two registries, the UK and Global Pregnancy and Neonatal outcomes in COVID-19 (PAN-COVID) study and the American Academy of Pediatrics (AAP) Section on Neonatal-Perinatal Medicine (SONPM) National Perinatal COVID-19 Registry. METHODS: This was an analysis of data from the PAN-COVID registry (1 January to 25 July 2020), which includes pregnancies with suspected or confirmed maternal SARS-CoV-2 infection at any stage in pregnancy, and the AAP-SONPM National Perinatal COVID-19 registry (4 April to 8 August 2020), which includes pregnancies with positive maternal testing for SARS-CoV-2 from 14 days before delivery to 3 days after delivery. The registries collected data on maternal, fetal, perinatal and neonatal outcomes. The PAN-COVID results are presented overall for pregnancies with suspected or confirmed SARS-CoV-2 infection and separately in those with confirmed infection. RESULTS: We report on 4005 pregnant women with suspected or confirmed SARS-CoV-2 infection (1606 from PAN-COVID and 2399 from AAP-SONPM). For obstetric outcomes, in PAN-COVID overall and in those with confirmed infection in PAN-COVID and AAP-SONPM, respectively, maternal death occurred in 0.5%, 0.5% and 0.2% of cases, early neonatal death in 0.2%, 0.3% and 0.3% of cases and stillbirth in 0.5%, 0.6% and 0.4% of cases. Delivery was preterm (< 37 weeks' gestation) in 12.0% of all women in PAN-COVID, in 16.1% of those women with confirmed infection in PAN-COVID and in 15.7% of women in AAP-SONPM. Extreme preterm delivery (< 27 weeks' gestation) occurred in 0.5% of cases in PAN-COVID and 0.3% in AAP-SONPM. Neonatal SARS-CoV-2 infection was reported in 0.9% of all deliveries in PAN-COVID overall, in 2.0% in those with confirmed infection in PAN-COVID and in 1.8% in AAP-SONPM; the proportions of neonates tested were 9.5%, 20.7% and 87.2%, respectively. The rates of a small-for-gestational-age (SGA) neonate were 8.2% in PAN-COVID overall, 9.7% in those with confirmed infection and 9.6% in AAP-SONPM. Mean gestational-age-adjusted birth-weight Z-scores were -0.03 in PAN-COVID and -0.18 in AAP-SONPM. CONCLUSIONS: The findings from the UK and USA registries of pregnancies with SARS-CoV-2 infection were remarkably concordant. Preterm delivery affected a higher proportion of women than expected based on historical and contemporaneous national data. The proportions of pregnancies affected by stillbirth, a SGA infant or early neonatal death were comparable to those in historical and contemporaneous UK and USA data. Although maternal death was uncommon, the rate was higher than expected based on UK and USA population data, which is likely explained by underascertainment of women affected by milder or asymptomatic infection in pregnancy in the PAN-COVID study, although not in the AAP-SONPM study. The data presented support strong guidance for enhanced precautions to prevent SARS-CoV-2 infection in pregnancy, particularly in the context of increased risks of preterm delivery and maternal mortality, and for priority vaccination of pregnant women and women planning pregnancy. Copyright © 2021 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Mullins E, Hudak ML, Banerjee J, et al. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol. 2021. PMID: 33620113. doi:10.1002/uog.23619
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。